[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786 432 9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 45, "title": "CEO & Chairman", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 337047, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Yanez M.B.A.", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 338774, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.11, "open": 1.0936, "dayLow": 1.06, "dayHigh": 1.11, "regularMarketPreviousClose": 1.11, "regularMarketOpen": 1.0936, "regularMarketDayLow": 1.06, "regularMarketDayHigh": 1.11, "payoutRatio": 0.0, "forwardPE": -2.1632652, "volume": 81979, "regularMarketVolume": 81979, "averageVolume": 321280, "averageVolume10days": 278710, "averageDailyVolume10Day": 278710, "bid": 0.7848, "ask": 1.36, "bidSize": 2, "askSize": 1, "marketCap": 17554554, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 5.01, "fiftyDayAverage": 1.12156, "twoHundredDayAverage": 1.31111, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13409943, "profitMargins": 0.0, "floatShares": 10569301, "sharesOutstanding": 16560900, "sharesShort": 980132, "sharesShortPriorMonth": 701873, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0592, "heldPercentInsiders": 0.23682, "heldPercentInstitutions": 0.06612, "shortRatio": 2.9, "shortPercentOfFloat": 0.078200005, "impliedSharesOutstanding": 17313600, "bookValue": 0.22, "priceToBook": 4.8181815, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -11240341, "trailingEps": -0.55, "forwardEps": -0.49, "52WeekChange": -0.018518507, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.06, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 4144560, "totalCashPerShare": 0.25, "totalDebt": 0, "quickRatio": 5.982, "currentRatio": 6.107, "returnOnAssets": -0.81267, "returnOnEquity": -1.9232299, "freeCashflow": -5502071, "operatingCashflow": -4790591, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "MIRA Pharmaceuticals, Inc.", "shortName": "MIRA Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1743197221, "regularMarketTime": 1743192001, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -4.504511, "regularMarketPrice": 1.06, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1692019800000, "postMarketChangePercent": 2.8302, "postMarketPrice": 1.09, "postMarketChange": 0.0300001, "regularMarketChange": -0.05000007, "regularMarketDayRange": "1.06 - 1.11", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 321280, "fiftyTwoWeekLowChange": 0.54999995, "fiftyTwoWeekLowChangePercent": 1.0784312, "fiftyTwoWeekRange": "0.51 - 5.01", "fiftyTwoWeekHighChange": -3.9500003, "fiftyTwoWeekHighChangePercent": -0.7884232, "fiftyTwoWeekChangePercent": -1.8518507, "epsTrailingTwelveMonths": -0.55, "epsForward": -0.49, "epsCurrentYear": -0.59, "priceEpsCurrentYear": -1.7966101, "fiftyDayAverageChange": -0.061560035, "fiftyDayAverageChangePercent": -0.05488787, "twoHundredDayAverageChange": -0.25111008, "twoHundredDayAverageChangePercent": -0.19152479, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]